Citigroup Inc Nrx Pharmaceuticals, Inc. Transaction History

Citigroup Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.2 - $8.07 $1,556 - $62,808	7,783 Added 797.44%	8,759 $6,000
Q2 2022 Aug 10, 2022	SELL	$0.51 - $2.42 $7,258 - $34,441	-14,232 Reduced 93.58%	976 $1,000
Q1 2022 May 12, 2022	BUY	$2.45 - $5.04 $29,071 - $59,804	11,866 Added 355.06%	15,208 $37,000
Q4 2021 Feb 10, 2022	BUY	$4.5 - $11.91 $12,883 - $34,098	2,863 Added 597.7%	3,342 $16,000
Q3 2021 Nov 10, 2021	BUY	$8.52 - $24.77 $4,081 - $11,864	479 New	479 $4,000

17.4K

Ticker NRXP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,641,296
Market Cap $102M
Description
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-10...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.